USPTO serial 79448735
ARATECAN
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEINPFAD, SARAH E
- Law office
- TMO LAW OFFICE 120
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ARATECAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Peptides, peptide derivatives, proteins, glycans, lipids, active principle antibody conjugates, antibody fragments, antibody derivatives, vectors for scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely, polypeptides, peptide derivatives for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for manufacturing pharmaceutical products. | ACTIVE | — |
| 005 | Pharmaceutical products and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular and biochemical genetic and biopharmaceutical products for medical and pharmaceutical use, namely peptides, peptide derivatives, active principle antibody conjugates, antibody fragments, antibody derivatives, vectors; pharmaceutical products and substances for disease treatment and preparations for medical treatments. | ACTIVE | — |
| 035 | Provision of information with respect to business contacts for research projects. | ACTIVE | — |
| 042 | Scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; biochemical or pharmaceutical laboratory services; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 2, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 2, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 24, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |